Skip to main content

Published locations for In IBD Patients, No Increased Risk for MACE Seen for JAK Inhibitors vs Anti-TNF

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. In IBD Patients, No Increased Risk for MACE Seen for JAK Inhibitors vs Anti-TNF

User login

  • Reset your password
  • /content/ibd-patients-no-increased-risk-mace-seen-jak-inhibitors-vs-anti-tnf
  • /gihepnews/article/271629/ibd-intestinal-disorders/ibd-patients-no-increased-risk-mace-seen-jak-inhibitors-vs-anti-tnf-0
  • /gihepnews/article/271629/ibd-intestinal-disorders/ibd-patients-no-increased-risk-mace-seen-jak-inhibitors-vs-anti-tnf
  • /cardiology/article/271629/ibd-intestinal-disorders/ibd-patients-no-increased-risk-mace-seen-jak-inhibitors-vs-anti-tnf
  • /internalmedicine/article/271629/ibd-intestinal-disorders/ibd-patients-no-increased-risk-mace-seen-jak-inhibitors-vs-anti-tnf
  • /familymedicine/article/271629/ibd-intestinal-disorders/ibd-patients-no-increased-risk-mace-seen-jak-inhibitors-vs-anti-tnf